Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


M&A Analysis – Acquisitions Come What May

Executive Summary

The steady flow of medtech M&A deal-making continued in May; Medtech Insight recorded 16 acquisitions last month, including a global merger of Sivantos and Widex to form the world's third-largest hearing-aid company, ready to challenge market leaders Sonova and William Demant.

You may also be interested in...

Stryker Makes Big Investment In Spine Surgery With $1.4Bn K2M Acquisition

The orthopedics giant will pay $27.50 per share for the Leesburg, Va., company, representing a 27% premium over K2M's average closing price over the last 90 days. The terms of the deal also call for K2M CEO to take over as president of Stryker's Spine business, displacing current president Bradley Paddock.

Philips Buys Heart Imaging Tech Firm Set Up By Biosense Founder

Philips is bulking-up its image-guided therapy portfolio with the acquisition of EPD Solutions, which has a recently CE-marked cardiac imaging and navigation system for ablation procedures to treat heart arrhythmias. EPD was founded by serial inventor and entrepreneur, Shlomo Ben-Haim, the man behind Johnson & Johnson's Biosense Webster business. 

Siemens Taps Dutch Start-Up ScreenPoint For AI Know-How In Breast Imaging

Siemens Healthineers has partnered up with ScreenPoint Medical, a young Dutch company, to codevelop artificial intelligence-based applications in breast-screening. The imaging giant has also taken an equity stake in ScreenPoint.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts